Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment
Primary Purpose
Retinal Detachment
Status
Unknown status
Phase
Phase 3
Locations
Mexico
Study Type
Interventional
Intervention
Vitrectomy
Sponsored by
About this trial
This is an interventional treatment trial for Retinal Detachment
Eligibility Criteria
Inclusion Criteria:
- Complicated retinal detachment with no more than 6months of evolution
Exclusion Criteria:
- Retinal detachments of more than 6 months of evolution No light perception
Sites / Locations
- Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes"Recruiting
Outcomes
Primary Outcome Measures
Perfluorocarbon liquids consumption
Secondary Outcome Measures
Full Information
NCT ID
NCT00404209
First Posted
June 30, 2006
Last Updated
November 29, 2007
Sponsor
Asociación para Evitar la Ceguera en México
1. Study Identification
Unique Protocol Identification Number
NCT00404209
Brief Title
Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment
Official Title
Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment
Study Type
Interventional
2. Study Status
Record Verification Date
November 2007
Overall Recruitment Status
Unknown status
Study Start Date
March 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
February 2008 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Asociación para Evitar la Ceguera en México
4. Oversight
5. Study Description
Brief Summary
To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Retinal Detachment
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Vitrectomy
Intervention Description
pressurized 23GA vitrectomy with a 3D system
Primary Outcome Measure Information:
Title
Perfluorocarbon liquids consumption
Time Frame
two months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Complicated retinal detachment with no more than 6months of evolution
Exclusion Criteria:
Retinal detachments of more than 6 months of evolution No light perception
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hugo Quiroz-Mercado, MD
Phone
5255 10841400
Ext
1171
Email
retinamex@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hugo Quiroz-Mercado, MD
Organizational Affiliation
Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Raul Velez-Montoya, MD
Organizational Affiliation
Asociación para Evitar la Ceguera en México
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes"
City
Mexico City
State/Province
Mexico DF
ZIP/Postal Code
04030
Country
Mexico
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hugo Quiroz-Mercado, MD
Phone
5255 10841400
Ext
1171
Email
retinamex@yahoo.com
First Name & Middle Initial & Last Name & Degree
Maria A Martinez-Castellanos, MD
First Name & Middle Initial & Last Name & Degree
Gerardo Garcia-Aguirre, MD
First Name & Middle Initial & Last Name & Degree
Orlando Ustariz-Gonzalez, MD
First Name & Middle Initial & Last Name & Degree
Jose L Guerrero-Naranjo, MD
First Name & Middle Initial & Last Name & Degree
Jans Fromow-Guerra, MD
12. IPD Sharing Statement
Learn more about this trial
Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment
We'll reach out to this number within 24 hrs